Reuters logo
BRIEF-Glaukos Corp says international study shows two Glaukos istent trabecular micro-bypass stents and one topical medication deliver sustained IOP reduction
April 13, 2017 / 11:21 AM / 8 months ago

BRIEF-Glaukos Corp says international study shows two Glaukos istent trabecular micro-bypass stents and one topical medication deliver sustained IOP reduction

April 13 (Reuters) - Glaukos Corp

* Glaukos Corp says international study shows two glaukos istent trabecular micro-bypass stents and one topical medication deliver sustained IOP reduction

* Safety profile was favorable with no intraoperative or device-related adverse events reported Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below